Semaglutide in Adolescents Living With Obesity: A Real‐World Data Study Exploring Predictors of Treatment Response
Valeria Cimador, Sophie Robertson, Christine Desmond, Jessica Dodgson, Elizabeth van Boxel, Nikki L. Davis, Rebecca J. Moon · 2026
Read Semaglutide in Adolescents Living With Obesity: A Real‐World Data Study Exploring Predictors of Treatment Response by Valeria Cimador, Sophie Robertson, Christine Desmond, Jessica Dodgson, Elizabeth van Boxel, Nikki L. Davis, Rebecca J. Moon (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13341411.txt.
Description
Valeria Cimador and colleagues studied semaglutide in 2026 in adolescents treated in routine care at two United Kingdom hospitals. Semaglutide improved body mass index and heart metabolic risk factors in teens in a controlled trial, yet drug effects often differ in routine care with more varied patients. Real world data for adolescents remained sparse.
The team analysed routinely collected clinical data for patients under 18 treated with semaglutide at University Hospital Southampton and a second centre. Weight and body mass index changes were tracked, with patient factors linked to response explored. The findings test whether trial gains hold for teens in everyday clinics.
Catalog record
| CREATOR | Valeria Cimador, Sophie Robertson, Christine Desmond, Jessica Dodgson, Elizabeth van Boxel, Nikki L. Davis, Rebecca J. Moon |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |